article thumbnail

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. Commercial.

article thumbnail

Wearable Technology in Healthcare

Tom Spencer

2 As questions on how to rein in increasing healthcare costs continue to mount, and politicians focus on passing legislation and targeting the pharmaceutical industry, a possible solution may be wearable health devices. Offers include things like gift cards and small cash payments for meeting certain daily fitness goals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Digital Health Care Can Help Prevent Chronic Diseases Like Diabetes

Harvard Business

DPPs typically include in-person meetings of a small group of prediabetic adults who, with the guidance of a health coach, progress through a diet and lifestyle curriculum. The company worked collaboratively with the CDC and was one the first three digital DPP providers that the agency recognized for meeting its evidence-based standards.

article thumbnail

Change Management Is Becoming Increasingly Data-Driven. Companies Aren’t Ready

Harvard Business

In a project for a pharmaceutical company, we were able to isolate the specific information sources that drove positive and negative sentiment toward the client’s brand. Developing these sorts of metrics will not be quick or easy. Automating the dashboard can make it more transparent and objective.

article thumbnail

To Seize the Future, Create a Leadership Circle

Harvard Business

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. Lastly, this group may be more attuned to individual interests (including performance metrics and compensation incentives) rather than the collective and longer-term needs of the firm. paul Garbett for HBR.

article thumbnail

Is Your Company as Ethical as It Seems?

Harvard Business

Despite having solid internal anti-corruption rules in place, the pharmaceutical giant wound up facing criminal investigations for bribing doctors and foreign officials , eventually paying a $489 million fine. The CEO of Volkswagen from 1993 to 2002 was famous for his willingness to demote or fire employees who failed to meet expectations.

Ethics 28
article thumbnail

If the SEC Measured CEO Pay Packages Properly, They Would Look Even More Outrageous

Harvard Business

Each publicly listed company reports both ARG and EFV measures of the stock-based pay of its CEO in the proxy statement that it files with the SEC in advance of its annual meeting of shareholders. And, for reasons explained below, ARG tends to be significantly higher than EFV, especially when the stock market is booming.